Company Profile
Inhibikase Therapeutics, Inc. is a pharmaceutical company focused on the development of protein kinase inhibitors for treatment of neurological infections and neurodegenerative diseases. The Company’s pipeline includes multiple product candidates developed from its proprietary RAMP drug innovation and prodrug technology engines, using the same clinically validated kinase target. The Company is headquartered in Atlanta with additional offices in Boston, Massachusetts.
Contact Information
Investor Relations
SternIR
Alex Lobo
T: 212-698-8802
alex.lobo@sternir.com
Company Contact
Inhibikase Therapeutics, Inc.
3350 Riverwood Parkway
Suite 1900
Atlanta, GA 30339
T: 678-392-3419
info@inhibikase.com